iShares Nasdaq Biotechnology Index Fund (IBB) Debt to Equity Ratio

Current and historical debt to equity ratio values for iShares Nasdaq Biotechnology Index Fund (IBB) over the last 10 years.

Sector Industry Market Cap Revenue
Finance Finance - Publicly Traded Investment Trusts $9.122B $0.000B
The ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index.